nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—schizophrenia	0.417	0.577	CbGaD
Clenbuterol—CYP1A2—schizophrenia	0.306	0.423	CbGaD
Clenbuterol—NGF—autonomic nervous system—schizophrenia	0.0256	0.35	CbGeAlD
Clenbuterol—NGF—forebrain—schizophrenia	0.00596	0.0815	CbGeAlD
Clenbuterol—NGF—telencephalon—schizophrenia	0.00548	0.0749	CbGeAlD
Clenbuterol—TNF—blood—schizophrenia	0.00432	0.059	CbGeAlD
Clenbuterol—NGF—blood—schizophrenia	0.00399	0.0545	CbGeAlD
Clenbuterol—CYP1A2—urine—schizophrenia	0.00355	0.0485	CbGeAlD
Clenbuterol—NGF—endocrine gland—schizophrenia	0.00346	0.0472	CbGeAlD
Clenbuterol—NGF—nervous system—schizophrenia	0.00324	0.0442	CbGeAlD
Clenbuterol—NGF—central nervous system—schizophrenia	0.00312	0.0426	CbGeAlD
Clenbuterol—NGF—brain—schizophrenia	0.00247	0.0338	CbGeAlD
Clenbuterol—CYP1A2—blood plasma—schizophrenia	0.00185	0.0253	CbGeAlD
Clenbuterol—ADRB1—forebrain—schizophrenia	0.00155	0.0212	CbGeAlD
Clenbuterol—ADRB1—telencephalon—schizophrenia	0.00143	0.0195	CbGeAlD
Clenbuterol—ADRB1—endocrine gland—schizophrenia	0.0009	0.0123	CbGeAlD
Clenbuterol—ADRB1—nervous system—schizophrenia	0.000842	0.0115	CbGeAlD
Clenbuterol—ADRB1—central nervous system—schizophrenia	0.000811	0.0111	CbGeAlD
Clenbuterol—CYP1A2—blood—schizophrenia	0.000678	0.00927	CbGeAlD
Clenbuterol—CYP1A1—blood—schizophrenia	0.000669	0.00915	CbGeAlD
Clenbuterol—ADRB1—brain—schizophrenia	0.000644	0.0088	CbGeAlD
Clenbuterol—CYP1A2—endocrine gland—schizophrenia	0.000588	0.00804	CbGeAlD
Clenbuterol—CYP1A1—endocrine gland—schizophrenia	0.00058	0.00793	CbGeAlD
Clenbuterol—CYP1A1—nervous system—schizophrenia	0.000543	0.00743	CbGeAlD
Clenbuterol—CYP1A1—central nervous system—schizophrenia	0.000523	0.00715	CbGeAlD
Clenbuterol—CYP1A1—brain—schizophrenia	0.000415	0.00568	CbGeAlD
Clenbuterol—ADRB2—Signaling by GPCR—OXT—schizophrenia	2.75e-05	0.000135	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.74e-05	0.000135	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—ESR1—schizophrenia	2.74e-05	0.000135	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—AKT1—schizophrenia	2.74e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—DRD3—schizophrenia	2.73e-05	0.000134	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—GSK3B—schizophrenia	2.72e-05	0.000134	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR1A—schizophrenia	2.71e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—DRD4—schizophrenia	2.71e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HTR2A—schizophrenia	2.71e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR1A—schizophrenia	2.7e-05	0.000133	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RGS4—schizophrenia	2.69e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM3—schizophrenia	2.69e-05	0.000132	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RTN4—schizophrenia	2.69e-05	0.000132	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	2.67e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NPS—schizophrenia	2.67e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NPS—schizophrenia	2.66e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR1A—schizophrenia	2.65e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—DRD4—schizophrenia	2.65e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR6—schizophrenia	2.64e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RTN4—schizophrenia	2.63e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RGS4—schizophrenia	2.63e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM3—schizophrenia	2.63e-05	0.000129	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NDUFV2—schizophrenia	2.62e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD1—schizophrenia	2.62e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR2C—schizophrenia	2.62e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NPS—schizophrenia	2.61e-05	0.000128	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD1—schizophrenia	2.61e-05	0.000128	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR2C—schizophrenia	2.61e-05	0.000128	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CNR1—schizophrenia	2.59e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR6—schizophrenia	2.58e-05	0.000127	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—AKT1—schizophrenia	2.57e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR2C—schizophrenia	2.56e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD1—schizophrenia	2.56e-05	0.000126	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAG—schizophrenia	2.55e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD3—schizophrenia	2.53e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NTRK2—schizophrenia	2.53e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CNR1—schizophrenia	2.53e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—DRD2—schizophrenia	2.52e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR7—schizophrenia	2.52e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD3—schizophrenia	2.52e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAG—schizophrenia	2.5e-05	0.000123	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—GSK3B—schizophrenia	2.49e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD3—schizophrenia	2.48e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—DRD2—schizophrenia	2.47e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR7—schizophrenia	2.47e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIP4K2A—schizophrenia	2.46e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD4—schizophrenia	2.46e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD4—schizophrenia	2.45e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	2.44e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD4—schizophrenia	2.41e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MPC2—schizophrenia	2.37e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CNR1—schizophrenia	2.35e-05	0.000116	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CNR1—schizophrenia	2.34e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CHRM1—schizophrenia	2.33e-05	0.000115	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.32e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CNR1—schizophrenia	2.3e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—DRD2—schizophrenia	2.29e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR7—schizophrenia	2.29e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CHRM1—schizophrenia	2.28e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR7—schizophrenia	2.28e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—DRD2—schizophrenia	2.28e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL3RA—schizophrenia	2.27e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR7—schizophrenia	2.24e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—DRD2—schizophrenia	2.24e-05	0.00011	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP26B1—schizophrenia	2.23e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL3RA—schizophrenia	2.23e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TLE1—schizophrenia	2.22e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRG3—schizophrenia	2.22e-05	0.000109	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	2.21e-05	0.000109	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—schizophrenia	2.21e-05	0.000108	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLCH2—schizophrenia	2.21e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GFAP—schizophrenia	2.19e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRG3—schizophrenia	2.17e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TLE1—schizophrenia	2.17e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM5—schizophrenia	2.17e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PRL—schizophrenia	2.15e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GFAP—schizophrenia	2.15e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM5—schizophrenia	2.12e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TLE3—schizophrenia	2.1e-05	0.000103	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NDST3—schizophrenia	2.07e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TLE3—schizophrenia	2.06e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—S100B—schizophrenia	2.01e-05	9.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TPH1—schizophrenia	1.99e-05	9.77e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GCLM—schizophrenia	1.99e-05	9.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCK—schizophrenia	1.98e-05	9.76e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ACSL6—schizophrenia	1.97e-05	9.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC27A5—schizophrenia	1.97e-05	9.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCK—schizophrenia	1.94e-05	9.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDE4B—schizophrenia	1.93e-05	9.51e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	1.92e-05	9.45e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB4—schizophrenia	1.92e-05	9.44e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCKAR—schizophrenia	1.9e-05	9.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDE4B—schizophrenia	1.89e-05	9.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DAO—schizophrenia	1.88e-05	9.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.87e-05	9.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PRKD1—schizophrenia	1.87e-05	9.18e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCKAR—schizophrenia	1.86e-05	9.15e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADORA2A—schizophrenia	1.85e-05	9.07e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PLA2G4A—schizophrenia	1.81e-05	8.92e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PLA2G4A—schizophrenia	1.81e-05	8.88e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADORA2A—schizophrenia	1.8e-05	8.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PNP—schizophrenia	1.8e-05	8.84e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—EP300—schizophrenia	1.79e-05	8.81e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PLA2G4A—schizophrenia	1.77e-05	8.73e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NRG1—schizophrenia	1.77e-05	8.71e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—FGA—schizophrenia	1.77e-05	8.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR2A—schizophrenia	1.77e-05	8.69e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MEF2C—schizophrenia	1.76e-05	8.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—FGA—schizophrenia	1.73e-05	8.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR2A—schizophrenia	1.73e-05	8.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NPY—schizophrenia	1.72e-05	8.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ATP2A2—schizophrenia	1.72e-05	8.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOTCH4—schizophrenia	1.72e-05	8.48e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—YWHAZ—schizophrenia	1.7e-05	8.35e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NPY—schizophrenia	1.69e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOTCH4—schizophrenia	1.69e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ATP2A2—schizophrenia	1.69e-05	8.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NDUFV2—schizophrenia	1.67e-05	8.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR1B—schizophrenia	1.66e-05	8.18e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—OXT—schizophrenia	1.66e-05	8.18e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ERBB3—schizophrenia	1.66e-05	8.16e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—EP300—schizophrenia	1.64e-05	8.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—OXT—schizophrenia	1.63e-05	8e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR1B—schizophrenia	1.63e-05	8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR2A—schizophrenia	1.61e-05	7.9e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR1A—schizophrenia	1.6e-05	7.87e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR2A—schizophrenia	1.6e-05	7.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NPS—schizophrenia	1.58e-05	7.75e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIP4K2A—schizophrenia	1.57e-05	7.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR2A—schizophrenia	1.57e-05	7.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR1A—schizophrenia	1.57e-05	7.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GAPDH—schizophrenia	1.56e-05	7.66e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2C—schizophrenia	1.55e-05	7.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD1—schizophrenia	1.55e-05	7.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CLOCK—schizophrenia	1.54e-05	7.6e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NPS—schizophrenia	1.54e-05	7.58e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	1.54e-05	7.58e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	1.52e-05	7.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD1—schizophrenia	1.51e-05	7.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2C—schizophrenia	1.51e-05	7.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TPH2—schizophrenia	1.51e-05	7.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CACNB2—schizophrenia	1.51e-05	7.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK2—schizophrenia	1.5e-05	7.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD3—schizophrenia	1.5e-05	7.36e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—schizophrenia	1.49e-05	7.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DPYD—schizophrenia	1.48e-05	7.28e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK2—schizophrenia	1.47e-05	7.23e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOA1—schizophrenia	1.47e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD3—schizophrenia	1.46e-05	7.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD4—schizophrenia	1.45e-05	7.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD4—schizophrenia	1.42e-05	6.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP26B1—schizophrenia	1.42e-05	6.99e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ESR1—schizophrenia	1.42e-05	6.97e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CNR1—schizophrenia	1.39e-05	6.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CACNA1C—schizophrenia	1.38e-05	6.77e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CNR1—schizophrenia	1.36e-05	6.68e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD2—schizophrenia	1.35e-05	6.66e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR7—schizophrenia	1.35e-05	6.66e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3C2A—schizophrenia	1.34e-05	6.6e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR7—schizophrenia	1.32e-05	6.51e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD2—schizophrenia	1.32e-05	6.51e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—GSK3B—schizophrenia	1.29e-05	6.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRL—schizophrenia	1.28e-05	6.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TPH1—schizophrenia	1.27e-05	6.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GCLM—schizophrenia	1.27e-05	6.23e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRL—schizophrenia	1.25e-05	6.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP2D6—schizophrenia	1.2e-05	5.92e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SNAP25—schizophrenia	1.2e-05	5.92e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	1.19e-05	5.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—S100B—schizophrenia	1.19e-05	5.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PRKD1—schizophrenia	1.19e-05	5.86e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—schizophrenia	1.17e-05	5.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—S100B—schizophrenia	1.17e-05	5.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB4—schizophrenia	1.14e-05	5.61e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB4—schizophrenia	1.12e-05	5.48e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP1A2—schizophrenia	1.09e-05	5.35e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—schizophrenia	1.08e-05	5.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TH—schizophrenia	1.07e-05	5.27e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PLA2G4A—schizophrenia	1.07e-05	5.27e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NRG1—schizophrenia	1.05e-05	5.17e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PLA2G4A—schizophrenia	1.05e-05	5.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MEF2C—schizophrenia	1.04e-05	5.13e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NRG1—schizophrenia	1.03e-05	5.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MEF2C—schizophrenia	1.02e-05	5.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—YWHAZ—schizophrenia	1.01e-05	4.95e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GAPDH—schizophrenia	9.94e-06	4.89e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—schizophrenia	9.89e-06	4.86e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—YWHAZ—schizophrenia	9.86e-06	4.85e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ERBB3—schizophrenia	9.85e-06	4.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CLOCK—schizophrenia	9.85e-06	4.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	9.83e-06	4.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	9.71e-06	4.78e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ERBB3—schizophrenia	9.64e-06	4.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TPH2—schizophrenia	9.6e-06	4.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CACNB2—schizophrenia	9.6e-06	4.72e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—schizophrenia	9.54e-06	4.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2A—schizophrenia	9.48e-06	4.66e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DPYD—schizophrenia	9.44e-06	4.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2A—schizophrenia	9.28e-06	4.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—COMT—schizophrenia	9.12e-06	4.48e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—schizophrenia	9.08e-06	4.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MAOA—schizophrenia	9.06e-06	4.45e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—schizophrenia	8.82e-06	4.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	8.78e-06	4.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CACNA1C—schizophrenia	8.78e-06	4.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOA1—schizophrenia	8.72e-06	4.29e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—schizophrenia	8.66e-06	4.26e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—schizophrenia	8.63e-06	4.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCB1—schizophrenia	8.59e-06	4.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3C2A—schizophrenia	8.56e-06	4.21e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOA1—schizophrenia	8.53e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EP300—schizophrenia	8.47e-06	4.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ESR1—schizophrenia	8.42e-06	4.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—schizophrenia	8.34e-06	4.1e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PLA2G4A—schizophrenia	8.34e-06	4.1e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ESR1—schizophrenia	8.24e-06	4.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SNAP25—schizophrenia	7.67e-06	3.77e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2D6—schizophrenia	7.67e-06	3.77e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GSK3B—schizophrenia	7.64e-06	3.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GSK3B—schizophrenia	7.47e-06	3.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—schizophrenia	7.37e-06	3.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—schizophrenia	6.86e-06	3.37e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TH—schizophrenia	6.84e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOA1—schizophrenia	6.78e-06	3.34e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—schizophrenia	6.06e-06	2.98e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—COMT—schizophrenia	5.82e-06	2.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—schizophrenia	5.79e-06	2.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MAOA—schizophrenia	5.77e-06	2.84e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—schizophrenia	5.66e-06	2.78e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.6e-06	2.75e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—schizophrenia	5.54e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCB1—schizophrenia	5.48e-06	2.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—schizophrenia	5.32e-06	2.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G4A—schizophrenia	5.32e-06	2.62e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—schizophrenia	5.14e-06	2.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—schizophrenia	5.12e-06	2.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—schizophrenia	5.03e-06	2.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EP300—schizophrenia	5.03e-06	2.47e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EP300—schizophrenia	4.92e-06	2.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—schizophrenia	4.7e-06	2.31e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—schizophrenia	4.38e-06	2.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA1—schizophrenia	4.33e-06	2.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—EP300—schizophrenia	3.91e-06	1.92e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—schizophrenia	3.6e-06	1.77e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—schizophrenia	3.52e-06	1.73e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—schizophrenia	3.04e-06	1.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—schizophrenia	2.97e-06	1.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EP300—schizophrenia	2.49e-06	1.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—schizophrenia	2.36e-06	1.16e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—schizophrenia	1.51e-06	7.41e-06	CbGpPWpGaD
